Paper of the Month - August, 2012

0 rating

Randomized control trial: evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported quality of life in women receiving external beam radiotherapy for treatment of stage 0, I, and II breast cancer.

Watson LC, Gies D, Thompson E et al.
There is an abundance of recommendations covering every aspect of daily life for women diagnosed with breast cancer. The authors of the present study investigated the use of antiperspirants in women receiving radiotherapy for early-stage breast cancer. The rationale for the study arose from the observation that guidelines discourage the application of perfume, deodorant, powder, and lotion on areas of the skin exposed to radiation treatment fields in order to reduce the risk of skin reactions to radiation.


Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?

Powered by NetPolls